Literature DB >> 8526502

Isolation and characterization of genetically engineered gallidermin and epidermin analogs.

B Ottenwälder1, T Kupke, S Brecht, V Gnau, J Metzger, G Jung, F Götz.   

Abstract

Gallidermin (Gdm) and epidermin (Epi) are highly homologous tetracyclic polypeptide antibiotics that are ribosomally synthesized by a Staphylococcus gallinarum strain and a Staphylococcus epidermidis strain, respectively. These antibiotics are secreted into media and are distinguished by the presence of the unusual amino acids lanthionine, 3-methyllanthionine, didehydrobutyrine, and S-(2-aminovinyl)-D-cysteine, which are formed by posttranslational modification. To study the substrate specificities of the modifying enzymes and to obtain variants that exhibit altered or new biological activities, we changed certain amino acids by performing site-specific mutagenesis with the Gdm and Epi structural genes (gdmA and epiA, respectively). S. epidermidis Tü3298/EMS6, an epiA mutant of the Epi-producing strain, was used as the expression host. This mutant synthesized Epi, Gdm, or analogs of these antibiotics when the appropriate genes were introduced on a plasmid. No Epi or Gdm analogs were isolated from the supernatant when (i) hydroxyamino acids involved in thioether amino acid formation were replaced by nonhydroxyamino acids (S3N and S19A); (ii) C residues involved in thioether bridging were deleted (delta C21, C22 and delta C22); or (iii) a ring amino acid was replaced by an amino acid having a completely different character (G10E and Y20G). A strong decrease in production was observed when S residues involved in thioether amino acid formation were replaced by T residues (S16T and S19T). A number of conservative changes at positions 6, 12, and 14 on the Gdm backbone were tolerated and led to analogs that had altered biological properties, such as enhanced antimicrobial activity (L6V) or a remarkable resistance to proteolytic degradation (A12L and Dhb14P). The T14S substitution led to simultaneous production of two Gdm species formed by incomplete posttranslational modification (dehydration) of the S-14 residue. The fully modified Dhb14Dha analog exhibited antimicrobial activity similar to that of Gdm, whereas the Dhb14S analog was less active. Both peptides were more sensitive to tryptic cleavage than Gdm was.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8526502      PMCID: PMC167695          DOI: 10.1128/aem.61.11.3894-3903.1995

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  32 in total

1.  The structure of nisin.

Authors:  E Gross; J L Morell
Journal:  J Am Chem Soc       Date:  1971-09-08       Impact factor: 15.419

2.  Mass spectroscopic analysis of a novel enzymatic reaction. Oxidative decarboxylation of the lantibiotic precursor peptide EpiA catalyzed by the flavoprotein EpiD.

Authors:  T Kupke; C Kempter; V Gnau; G Jung; F Götz
Journal:  J Biol Chem       Date:  1994-02-25       Impact factor: 5.157

3.  [Subtilin, VI: the structure of subtilin (author's transl)].

Authors:  E Gross; H H Kiltz; E Nebelin
Journal:  Hoppe Seylers Z Physiol Chem       Date:  1973-07

4.  Regulation of epidermin biosynthetic genes by EpiQ.

Authors:  A Peschel; J Augustin; T Kupke; S Stevanovic; F Götz
Journal:  Mol Microbiol       Date:  1993-07       Impact factor: 3.501

5.  Construction of an expression system for engineering of the lantibiotic Pep5.

Authors:  G Bierbaum; M Reis; C Szekat; H G Sahl
Journal:  Appl Environ Microbiol       Date:  1994-12       Impact factor: 4.792

6.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

7.  Sequence analysis of lantibiotics: chemical derivatization procedures allow a fast access to complete Edman degradation.

Authors:  H E Meyer; M Heber; B Eisermann; H Korte; J W Metzger; G Jung
Journal:  Anal Biochem       Date:  1994-12       Impact factor: 3.365

Review 8.  Lantibiotics--unusually modified bacteriocin-like peptides from gram-positive bacteria.

Authors:  G Bierbaum; H G Sahl
Journal:  Zentralbl Bakteriol       Date:  1993-02

9.  Genetic and biochemical analyses of the biosynthesis of the yellow carotenoid 4,4'-diaponeurosporene of Staphylococcus aureus.

Authors:  B Wieland; C Feil; E Gloria-Maercker; G Thumm; M Lechner; J M Bravo; K Poralla; F Götz
Journal:  J Bacteriol       Date:  1994-12       Impact factor: 3.490

10.  Oxidative decarboxylation of peptides catalyzed by flavoprotein EpiD. Determination of substrate specificity using peptide libraries and neutral loss mass spectrometry.

Authors:  T Kupke; C Kempter; G Jung; F Götz
Journal:  J Biol Chem       Date:  1995-05-12       Impact factor: 5.157

View more
  20 in total

1.  Antimicrobial activity of community-associated methicillin-resistant Staphylococcus aureus is caused by phenol-soluble modulin derivatives.

Authors:  Hwang-Soo Joo; Gordon Y C Cheung; Michael Otto
Journal:  J Biol Chem       Date:  2011-01-28       Impact factor: 5.157

2.  Insights into in vivo activities of lantibiotics from gallidermin and epidermin mode-of-action studies.

Authors:  Raquel Regina Bonelli; Tanja Schneider; Hans-Georg Sahl; Imke Wiedemann
Journal:  Antimicrob Agents Chemother       Date:  2006-04       Impact factor: 5.191

Review 3.  Post-translational modifications of lantibiotics.

Authors:  T Kupke; F Götz
Journal:  Antonie Van Leeuwenhoek       Date:  1996-02       Impact factor: 2.271

4.  Carboxyl Analogue of Mutacin 1140, a Scaffold for Lead Antibacterial Discovery.

Authors:  Jerome Escano; Akshaya Ravichandran; Bita Salamat; Leif Smith
Journal:  Appl Environ Microbiol       Date:  2017-06-30       Impact factor: 4.792

5.  Activity of gallidermin on Staphylococcus aureus and Staphylococcus epidermidis biofilms.

Authors:  Jongkon Saising; Linda Dube; Anne-Kathrin Ziebandt; Supayang Piyawan Voravuthikunchai; Mulugeta Nega; Friedrich Götz
Journal:  Antimicrob Agents Chemother       Date:  2012-08-27       Impact factor: 5.191

6.  Circumventing the effect of product toxicity: development of a novel two-stage production process for the lantibiotic gallidermin.

Authors:  G Valsesia; G Medaglia; M Held; W Minas; S Panke
Journal:  Appl Environ Microbiol       Date:  2006-12-28       Impact factor: 4.792

7.  Synthesis of trypsin-resistant variants of the Listeria-active bacteriocin salivaricin P.

Authors:  Eileen F O'Shea; Paula M O'Connor; Paul D Cotter; R Paul Ross; Colin Hill
Journal:  Appl Environ Microbiol       Date:  2010-06-25       Impact factor: 4.792

8.  Construction of an expression system for site-directed mutagenesis of the lantibiotic mersacidin.

Authors:  Christiane Szekat; Ralph W Jack; Dirk Skutlarek; Harald Färber; Gabriele Bierbaum
Journal:  Appl Environ Microbiol       Date:  2003-07       Impact factor: 4.792

9.  Site-directed mutations in the lanthipeptide mutacin 1140.

Authors:  Shaorong Chen; Shawanda Wilson-Stanford; William Cromwell; Jeffrey D Hillman; Adam Guerrero; Charlotte A Allen; Joseph A Sorg; Leif Smith
Journal:  Appl Environ Microbiol       Date:  2013-04-19       Impact factor: 4.792

10.  Insights into the mode of action of the two-peptide lantibiotic haloduracin.

Authors:  Trent J Oman; Wilfred A van der Donk
Journal:  ACS Chem Biol       Date:  2009-10-16       Impact factor: 5.100

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.